ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vanderbilt Health Performs First Successful Kidney Transplant Using New Organ Preservation Technology

Vanderbilt University Hospital becomes first hospital in Tennessee to adopt advanced preservation technology for kidney transplantation to expand the donor pool

Paragonix Technologies, Inc., a leader in organ preservation technology, and Vanderbilt Health, one of the oldest and largest kidney transplant programs in the country, are proud to announce the successful transplantation of a donor kidney using the Paragonix KidneyVault™ Renal Perfusion System. The FDA-cleared portable hypothermic perfusion technology is designed to preserve and transport donor kidneys. Vanderbilt is the first in Tennessee, and one of the first in the entire Southeast to use this innovative system for kidney transport.

The adoption of KidneyVault is the latest advancement in Vanderbilt’s commitment to leveraging cutting-edge technology in the organ transplantation process. By pioneering new approaches, Vanderbilt is able to serve more patients, including high-risk patients who may not be candidates at other medical centers.

“We used the technology for transport and pumping and were satisfied with the overall feel and appearance of the kidney at the time of reperfusion,” said Christian Crannell, MD, Assistant Professor of Surgery in the Division of Kidney & Pancreas Transplantation. “We also appreciated knowing where the kidney was during transport and knowing the organ temperature.”

More than 106,000 patients are currently on the national transplant waitlist in the U.S., with 86% waiting for a kidney. Expanding donor pools and optimizing available resources is critical. Hypothermic machine perfusion has shown significant benefits for kidney transplants. KidneyVault’s compact and easy-to-transport design combines proven perfusion techniques with advanced digital monitoring, ensuring donor kidneys arrive in optimal condition and improving the process from donation to recipient.

“Paragonix is committed to expanding access to donor organs and improving patient outcomes, and we’re thrilled to see Vanderbilt Health introduce KidneyVault to its community,” said Lisa Anderson, Ph.D., President of Paragonix Technologies. “Innovations like KidneyVault enable transplant centers to accept organs from greater distances and with more logistical complexity than ever before. We look forward to empowering the clinical community to maximize the use of Paragonix devices, giving every donor kidney the best chance to reach a patient in need.”

For more information about Paragonix Advanced Organ Preservation devices, please visit www.paragonix.com.

About Paragonix Technologies

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation.

A Getinge company, Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Their FDA-cleared and CE-marked devices incorporate clinically proven and medically trusted cold preservation techniques that allow unprecedented physical and thermal protection to the organ during transit. All Paragonix AOP devices are natively integrated with a novel digital app, delivering real-time organ tracking data and monitoring logistics for transplant teams seeking a secure and centralized solution. For more information, visit www.paragonix.com.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile processing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

Connect with us on LinkedIn: Paragonix Technologies

Follow us on X (formerly twitter): @ParagonixSherpa

Find us on YouTube: Paragonix SherpaPak

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.